Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 11 , ISSUE 1 ( January-February, 2019 ) > List of Articles


Women's Perceptions and Practices on Human Papillomavirus Infection and Human Papillomavirus Vaccine in Sri Lankan Community

Chinthika P Gunasekara, Irangi Karunanayake, Nirasha Premathilake, Nawashika H Senarathna, Ishanka Udayangani, Manjula M Weerasekara, Ramya Pathiraja, Neluka Fernando

Keywords : Attitudes, Cervical cancer, HPV vaccine, Human papillomavirus, Knowledge, Practices, Sri Lanka

Citation Information : Gunasekara CP, Karunanayake I, Premathilake N, Senarathna NH, Udayangani I, Weerasekara MM, Pathiraja R, Fernando N. Women's Perceptions and Practices on Human Papillomavirus Infection and Human Papillomavirus Vaccine in Sri Lankan Community. J South Asian Feder Obs Gynae 2019; 11 (1):65-69.

DOI: 10.5005/jp-journals-10006-1652

License: CC BY-NC 4.0

Published Online: 01-12-2017

Copyright Statement:  Copyright © 2019; The Author(s).


Aim: This study investigated the knowledge, perceptions, and practices regarding human papilloma virus (HPV) infection among women attending gynecology clinic and antenatal clinic at a teaching hospital in Sri Lanka. Materials and methods: A cross-sectional survey was conducted of 400 women attending gynecology and antenatal clinics at a teaching hospital between September 2015 and December 2015. A pretested self-administered questionnaire was used to collect data. A score of ≥ 75% was considered as good while 74.50% was considered as moderate and < 50% as poor. Results: Out of 400 women who participated in this study, the percentage of respondents who had heard of HPV, cervical cancer (CC) and genital warts were 23%, 80%, and 41% respectively. However, only 16% knew that there is an association between HPV and CC. Although 48% believed that CC is common in Sri Lanka, only 6.8% considered themselves at risk. Overall knowledge of risk factors, symptoms, transmission and diagnosis was 44% (CC) and 14% (HPV infection) respectively. Only 14.3% was aware of the availability of the HPV vaccine in Sri Lanka. None of the participants in the study group had received the HPV vaccine. Conclusion: This population had poor knowledge, attitudes, and practices with regard to HPV infection. Clinical significance: Therefore substantial effort should be made to educate the society regarding HPV infection, complications, and preventive measures.

PDF Share
  1. Organization WH. Cervical Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012. GLOBOCAN 2012 (IARC), Section of Cancer Surveillance; 2012.
  2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2015;136(5):E359-E386.
  3. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet- Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012 Nov 20;30:F12-F23.
  4. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. Journal of Clinical Virology. 2005 Mar 1;32:16-24.
  5. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. International Journal of Cancer. 2007 Aug 1;121(3):621-632.
  6. Karunaratne K. Prophylactic HPV vaccination–current status. Sri Lanka Journal of Obstetrics and Gynaecology. 2012;32(2):25-26.
  7. Ministry of Health, Government of the Democratic Socialist Republic of Sri Lanka. Comprehensive Multi-year Plan for Immunization 2012-2016.
  8. Ariyaratne MHJD Gunasekara TDCP, Weerasekara MM, Kottahachch J, Kudavidanage BP, Fernando SSN. Knowledge, attitudes and practices of hand hygiene among final year medical and nursing students at the University of Sri Jayewardenepura. Sri Lankan Journal of Infectious Diseases. 2013;3(1):15-25.
  9. Suchitra JB, Lakshmi Devi N. Impact of education on knowledge, attitudes and practices among various categories of health care workers on nosocomial infections. Indian Journal of Medical Microbiology. 2007 Jul;25(3):181-187.
  10. Johnson DC, Bhatta MP, Gurung S, Aryal S, Lhaki P, Shrestha S. Knowledge and awareness of human papillomavirus (HPV), cervical cancer and HPV vaccine among women in two distinct Nepali communities. Asian Pacific Journal of Cancer Prevention: APJCP. 2014;15(19):8287-8293.
  11. Wang SM, Zhang SK, Pan XF, Ren ZF, Yang CX, Wang ZZ, et al. Human papillomavirus vaccine awareness, acceptability, and decision-making factors among Chinese college students. Asian Pacific Journal of Cancer Prevention: APJCP. 2014;15(7):3239-3245.
  12. Ezat SW, Hod R, Mustafa J, Mohd D, Ahmad ZH, Sulaiman AS, et al. National HPV immunisation programme: knowledge and acceptance of mothers attending an obstetrics clinic at a teaching hospital, Kuala Lumpur. Asian Pacific Journal of Cancer Prevention. 2013;14(5):2991-2999.
  13. Abudukadeer A, Ding Y, Niyazi M, Ababaikeli A, Abudula A. Distribution of HPV genotypes in uterine cervical lesions among the Uighur women in Xinjiang province of China. European Journal of Gynaecological Oncology. 2010 Jan 1;31(3):315.
  14. Östh J. Knowledge of Human Papilloma Virus, Cervical Cancer and Cytological Screening and Attitudes towards and Practices of Screening among Undergraduate students at Rajarata University, Sri Lanka: A cross-sectional study. 2015.
  15. Stöcker P, Dehnert M, Schuster M, Wichmann O, Deleré Y. Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010. Human Vaccines and Immunotherapeutics. 2013;9(1):74-82.
  16. Kaarthigeyan K. Cervical cancer in India and HPV vaccination. Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical & Paediatric Oncology. 2012 Jan-Mar;33(1):7-12.
  17. Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of HPV After Introduction of the Vaccination Program in the United States. Pediatrics. 2016 Mar;137(3):e20151968.
  18. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet (London, England). 2007 Jun 30;369(9580):2161-2170.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.